Yale University

Routine human immunodeficiency virus testing: an economic evaluation of current guidelines.

TitleRoutine human immunodeficiency virus testing: an economic evaluation of current guidelines.
Publication TypeJournal Article
Year of Publication2005
AuthorsWalensky, Rochelle P., Milton C. Weinstein, April D. Kimmel, George R. Seage, Elena Losina, Paul E. Sax, Hong Zhang, Heather E. Smith, Kenneth A. Freedberg, and David A. Paltiel
JournalThe American journal of medicine
Volume118
Issue3
Pagination292-300
Date Published2005 Mar
ISSN0002-9343
KeywordsCenters for Disease Control and Prevention (U.S.), Cost-Benefit Analysis, Female, Guidelines as Topic, HIV, HIV Infections, Humans, Male, Mass Screening, Middle Aged, Sensitivity and Specificity, United States
AbstractThe Centers for Disease Control and Prevention guidelines recommend human immunodeficiency virus (HIV) counseling, testing, and referral for all patients in hospitals with an HIV prevalence of >or=1%. The 1% screening threshold has not been critically examined since HIV became effectively treatable in 1995. Our objective was to evaluate the clinical effect and cost-effectiveness of current guidelines and of alternate HIV prevalence thresholds.
DOI10.1111/j.1524-4733.2010.00763.x
Alternate JournalAm. J. Med.

External Links